Biora Therapeutics Stock Probability of Future Stock Price Finishing Under 1.67
| BIOR Stock | USD 1.67 0.04 2.45% |
Biora |
Biora Therapeutics Target Price Odds to finish below 1.67
The tendency of Biora Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 1.67 | 90 days | 1.67 | under 4 |
Based on a normal probability distribution, the odds of Biora Therapeutics to move below current price in 90 days from now is under 4 (This Biora Therapeutics probability density function shows the probability of Biora Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.67 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biora Therapeutics will likely underperform. Additionally Biora Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Biora Therapeutics Price Density |
| Price |
Predictive Modules for Biora Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biora Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biora Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biora Therapeutics is not an exception. The market had few large corrections towards the Biora Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biora Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biora Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.05 | |
β | Beta against Dow Jones | 1.67 | |
σ | Overall volatility | 1.70 | |
Ir | Information ratio | -0.31 |
Biora Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biora Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biora Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biora Therapeutics generated a negative expected return over the last 90 days | |
| Biora Therapeutics has high historical volatility and very poor performance | |
| Biora Therapeutics may become a speculative penny stock | |
| Biora Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4 K. Net Loss for the year was (124.11 M) with profit before overhead, payroll, taxes, and interest of 1.25 M. | |
| Biora Therapeutics currently holds about 37.06 M in cash with (48.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Biora Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Wainwright lifts Biora Therapeutics stock target, keeps Buy rating on Q3 report |
Biora Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biora Stock often depends not only on the future outlook of the current and potential Biora Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biora Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.8 M | |
| Cash And Short Term Investments | 15.2 M |
Biora Therapeutics Technical Analysis
Biora Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Biora Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biora Therapeutics. In general, you should focus on analyzing Biora Stock price patterns and their correlations with different microeconomic environments and drivers.
Biora Therapeutics Predictive Forecast Models
Biora Therapeutics' time-series forecasting models is one of many Biora Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biora Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biora Therapeutics
Checking the ongoing alerts about Biora Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biora Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biora Therapeutics generated a negative expected return over the last 90 days | |
| Biora Therapeutics has high historical volatility and very poor performance | |
| Biora Therapeutics may become a speculative penny stock | |
| Biora Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4 K. Net Loss for the year was (124.11 M) with profit before overhead, payroll, taxes, and interest of 1.25 M. | |
| Biora Therapeutics currently holds about 37.06 M in cash with (48.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19. | |
| Biora Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Wainwright lifts Biora Therapeutics stock target, keeps Buy rating on Q3 report |
Additional Tools for Biora Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.